Literature DB >> 10749340

Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.

T Ichikawa1, K Ishihara, H Hayashida, H Hiruma, K Saigenji, K Hotta.   

Abstract

The effects of ecabet sodium (ecabet), 12-sulfodehydroabietic acid monosodium salt, on gastric mucin biosynthesis in rat antrum were compared with those in the corpus. Intragastric administration of ecabet significantly increased [3H]glucosamine incorporation into antral mucin as well as into corpus mucin during five successive hours of organ culture. In contrast, mucin biosynthesis in either antrum or corpus was not susceptible to the addition of ecabet to the culture medium. Ecabet-induced stimulation of prostaglandin E2 production in the antrum was essentially the same as that seen in the corpus. In antrum treated with 100 mg/kg ecabet, immunoreactivity with three distinct anti-mucin monoclonal antibodies was found not only in the specific mucus-producing cells, but also in the secreted mucus present at the surface gel layer. These results suggest that ecabet enhances the mucin metabolism, and this stimulation occurs in both the corpus and antrum, suggesting that ecabet might be a useful tool for the further clarification of the regulatory mechanism of antral mucin synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749340     DOI: 10.1023/a:1005469913079

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  38 in total

1.  Two types of rat gastric mucus glycoprotein subunits.

Authors:  S Ohara; K Ishihara; K Hotta
Journal:  J Biochem       Date:  1988-06       Impact factor: 3.387

Review 2.  Gastric mucus and the mucosal barrier.

Authors:  B L Slomiany; J Sarosiek; A Slomiany
Journal:  Dig Dis       Date:  1987       Impact factor: 2.404

3.  Stimulation and inhibition of prostacyclin formation in the gastric mucosa and ileum in vitro by anti-inflammatory agents.

Authors:  N K Boughton-Smith; B J Whittle
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

4.  Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats.

Authors:  Y Onoda; T Magaribuchi; H Tamaki
Journal:  Jpn J Pharmacol       Date:  1989-09

5.  Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury.

Authors:  A Robert; J E Nezamis; C Lancaster; A J Hanchar
Journal:  Gastroenterology       Date:  1979-09       Impact factor: 22.682

6.  Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.

Authors:  Y Onoda; M Takido; T Magaribuchi; H Tamaki
Journal:  Jpn J Pharmacol       Date:  1990-04

7.  Regulation of canine gastric mucin synthesis and phospholipid secretion by acid secretagogues.

Authors:  J M Scheiman; E R Kraus; C R Boland
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

8.  Inhibition of Helicobacter pylori colonization by sulfated gastric mucin.

Authors:  J Piotrowski; A Slomiany; V L Murty; Z Fekete; B L Slomiany
Journal:  Biochem Int       Date:  1991-07

9.  Ca2+-dependent and -independent secretagogue action on gastric mucus secretion in rabbit mucosal explants.

Authors:  U Seidler; K F Sewing
Journal:  Am J Physiol       Date:  1989-04

10.  Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.

Authors:  M Kinoshita; H Iwasaki; A Yasoshima; H Tamaki
Journal:  Biol Pharm Bull       Date:  1993-12       Impact factor: 2.233

View more
  5 in total

1.  Role of mucus reduction and luminal acid elevation in increased susceptibility of stomach to nonsteroidal antiinflammatory drug-induced injury in arthritic rats.

Authors:  K Okuyama; M Jinbo; N Saito; S Igarashi; H Narita; M Kinoshita
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Safety and tolerability of bismuthyl ecabet suspension, a novel anti-ulcer agent, following single and multiple oral dose administration in healthy Chinese subjects.

Authors:  Yongqing Wang; Nana Tang; Ling Meng; Peipei Zhang; Kun Xu; Ningling Jiang; Haibo Zhang; Ning Ou; Deqin Wu; Anjiu Chen; Xiyong Zhang; Ruihua Shi
Journal:  Clin Drug Investig       Date:  2012-04-01       Impact factor: 2.859

3.  Therapeutic effects of ecabet sodium, an antiulcer drug, on dextran sodium sulfate-induced ulcerative colitis in rats.

Authors:  Tsunehisa Noto; Hiroshi Yamada; Takashi Inui; Kayoko Okuyama; Ayako Watanable; Isami Kimura; Masaaki Nagasaki
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

4.  Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial.

Authors:  Jun Haeng Lee; Jae J Kim; Ki-Baik Hahm; Dong Ho Lee; Nayoung Kim; Sung Kook Kim; Jong Jae Park; Seok Reyol Choi; Jong Hun Lee; Soo Teik Lee; Eun Hyun Lee; Jong Chul Rhee
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

5.  Efficacy of ecabet sodium enema on intractable rectal ulcer after piecemeal endoscopic mucosal resection for rectal tumor.

Authors:  Kyoko Yoshioka; Yoshitaka Ueno; Shinji Tanaka; Kenta Nagai; Toshiko Onitake; Rie Hanaoka; Kazuaki Chayama
Journal:  Clin J Gastroenterol       Date:  2010-09-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.